Inactive Instrument

Highlights Pfizer Inc Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 29	J&J, Bristol Myers lose challenges to US drug price negotiation program	RE
Apr. 29	Pfizer, Genmab Get Full FDA Approval for Cervical-Cancer Drug	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

J&J, Bristol Myers lose challenges to US drug price negotiation program	Apr. 29	RE
Tesla Rally Boosts S&P 500, Nasdaq; This Week's Earnings, Fed Decision in Focus	Apr. 29	MT
Equity Markets Rise With Key Earnings, Fed Decision in Focus	Apr. 29	MT
Equities Higher as Traders Await This Week's Key Earnings, Fed Decision	Apr. 29	MT
S&P 500 Companies' Latest Quarterly Results Mixed so Far, Oppenheimer Says	Apr. 29	MT
CAC40: limited erosion, despite the beginnings of a rate cut	Apr. 29	CF
Pfizer: presents new data at ASCO 2024	Apr. 29	CF
CAC40: starts the week slightly up, crosses the 8100 mark	Apr. 29	CF
S&P 500 Posts First Weekly Gain Since March as Tech, Consumer Discretionary Lead Rise on Better-Than-Expected Earnings	Apr. 26	MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon	Apr. 26	MT
Sector Update: Health Care Stocks Mixed Premarket Friday	Apr. 26	MT
US FDA approves Pfizer's gene therapy for rare bleeding disorder	Apr. 26	RE
U.S. FDA Approves Pfizer Inc.'s Beqvez (Fidanacogene Elaparvovec-Dzkt), A One-Time Gene Therapy for Adults with Hemophilia B	Apr. 26	CI
Sector Update: Health Care Stocks Drop in Afternoon Trading	Apr. 25	MT
GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines	Apr. 25	MT
GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines	Apr. 25	MT
GSK Files Lawsuit Against Pfizer, BioNTech Over mRNA Patents Infringement	Apr. 25	MT
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology	Apr. 25	RE
Bristol Myers posts quarterly loss, revenue rises 5%	Apr. 25	RE
Scholz promises support for pharma sector in Germany as Merck invests	Apr. 25	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm EDT